Beam Therapeutics Inc

NASDAQ:BEAM   3:59:55 PM EDT
93.74
-1.23 (-1.30%)
Earnings Announcements

Beam Therapeutics Announces Reports Q4 2020 Financial Results

Published: 03/15/2021 10:51 GMT
Beam Therapeutics Inc (BEAM) - Q4 Loss per Share $1.69.
Q4 Earnings per Share Estimate $-0.67 -- Refinitiv Ibes Data (analyst estimates).company On-track to Submit First Ind With Beam-101 in Second Half of 2021.
Revenue is expected to be $8.22 Million
Adjusted EPS is expected to be -$0.70

Next Quarter Revenue Guidance is expected to be $0.94 Million
Next Quarter EPS Guidance is expected to be -$0.93

More details on our Analysts Page.